1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
679FE45C8F9FEF1B785256E62005F9017
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/enhancing-business-value-turning-data-into-intelligence-and-market-insights?opendocument
18
19opendocument
203.88.156.58
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Market Research, Analytics and Forecasting Process Excellence and Productivity Management

Enhancing Business Value: Turning Data into Intelligence and Market Insights

DB Image

ID: 4585


Features:

Metrics, Graphics


Words: 5,768


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Study Overview

Transforming data into useful intelligence is a central challenge that managers of market research organizations face. However, this process is critical to heightening the success of a company’s business. Market researchers must be able to proactively develop and communicate relevant insights and actionable recommendations to brand or category leaders based on a perceptive analysis of market facts, data and trends.

Key Topics
By reading this 22-page document, market research executives can employ practices to train staff on developing relevant insights, manage the quality of insights and recommendations and develop formats for effective communication of insights. Benchmark survey data, conceptual graphics and executive quotes are also incorporated into this document.

Sample Best Practices

  1. Integrate competitive intelligence skills into the overall market research function to forge deeper insights about the market and competition.
    - Among leading pharmaceutical market research organizations, field research reveals 70 percent identify competitive intelligence as an important component of their group structures.
  2. Proactively propose research projects that emerge during market analysis and reflect new growth opportunities for your company’s brands.
    -When the Senior Manager of Global Market Analytics at one leading company spots a project that could help grow the business, he proactively presents it to the appropriate business leader as a place where market research can help.
  3. Designate a market research executive to oversee and approve the group’s final output to ensure quality of insights and consistency of format.
    -One Market Research Head strongly believes that market research leaders are the final gatekeepers who ensure research quality and consistency. This director personally signs off on all reports and findings with recommendations for improvement.
Methodology
This research originates from a Best Practices, LLC consulting project for a client and is based on interviews and surveys with market research benchmark partners.

For further questions on this research or if your company would like to explore opportunities to work with Best Practices, LLC to conduct customized
benchmarking research, contact Tracy Hollister at 919-767-9225.

Industries Profiled:
Pharmaceutical; Insurance; Medical Device; Telecommunications; Research; Health Care; Biotech; Shipping; Manufacturing; Consumer Products; Diagnostic; Chemical; Computer Hardware; Computers; High Tech; Electronics


Companies Profiled:
AstraZeneca; Sanofi-aventis; Zurich North American; Towers Perrin; Royal & SunAlliance; Raymond Corporation; Ranbaxy; Penn National Insurance; Alexion Pharmaceuticals; 3M Pharmaceuticals; Aliant Telecom; LexisNexis; Arrow International; aaiPharma; Centocor; Inc.; Abbott Laboratories; DSM Pharmaceutical; Mattson Jack Group; FedEx; GE Financial; Bayer; Genentech; Bristol-Myers Squibb; Hewlett-Packard; DuPont; IBM; Eli Lilly; Janssen; Ortho Biotech; Roche; Mead Corp; Merck; MetLife; NCR; Novartis; Novo Nordisk; Organon; Texas Instruments; Dow Chemical; Xerox


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.